nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—hindbrain—amyotrophic lateral sclerosis	0.101	0.202	CbGeAlD
Lucanthone—APEX1—embryo—amyotrophic lateral sclerosis	0.0634	0.127	CbGeAlD
Lucanthone—APEX1—brainstem—amyotrophic lateral sclerosis	0.0581	0.116	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.046	0.101	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0444	0.0978	CbGpPWpGaD
Lucanthone—Amiodarone—SIGMAR1—amyotrophic lateral sclerosis	0.0443	1	CrCbGaD
Lucanthone—APEX1—medulla oblongata—amyotrophic lateral sclerosis	0.0405	0.0809	CbGeAlD
Lucanthone—APEX1—spinal cord—amyotrophic lateral sclerosis	0.0361	0.0721	CbGeAlD
Lucanthone—APEX1—nervous system—amyotrophic lateral sclerosis	0.0305	0.0608	CbGeAlD
Lucanthone—APEX1—central nervous system—amyotrophic lateral sclerosis	0.0293	0.0585	CbGeAlD
Lucanthone—APEX1—cerebellum—amyotrophic lateral sclerosis	0.0287	0.0572	CbGeAlD
Lucanthone—TOP1—medulla oblongata—amyotrophic lateral sclerosis	0.0284	0.0566	CbGeAlD
Lucanthone—TOP1—spinal cord—amyotrophic lateral sclerosis	0.0253	0.0504	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP9—amyotrophic lateral sclerosis	0.0235	0.0518	CbGpPWpGaD
Lucanthone—APEX1—brain—amyotrophic lateral sclerosis	0.0233	0.0464	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.0226	0.0498	CbGpPWpGaD
Lucanthone—TOP1—cerebellum—amyotrophic lateral sclerosis	0.0201	0.04	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.0184	0.0406	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.0179	0.0395	CbGpPWpGaD
Lucanthone—TOP1—brain—amyotrophic lateral sclerosis	0.0163	0.0325	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.0146	0.0322	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.0145	0.0318	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0139	0.0306	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0127	0.0279	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.0123	0.0271	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.0118	0.026	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.0116	0.0255	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.0111	0.0244	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP3—amyotrophic lateral sclerosis	0.0099	0.0218	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00894	0.0197	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00858	0.0189	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00754	0.0166	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.00748	0.0165	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00719	0.0158	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00706	0.0155	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00603	0.0133	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00603	0.0133	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00576	0.0127	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.00539	0.0119	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.00539	0.0119	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.00512	0.0113	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00489	0.0108	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.00458	0.0101	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00406	0.00893	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00403	0.00886	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00396	0.00871	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00384	0.00845	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00376	0.00829	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.00374	0.00823	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00369	0.00812	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00361	0.00796	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.00353	0.00778	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—amyotrophic lateral sclerosis	0.00323	0.00711	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00319	0.00703	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00279	0.00615	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00279	0.00613	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00279	0.00613	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.00249	0.00548	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.00249	0.00548	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00241	0.00531	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.0024	0.00528	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.00237	0.00522	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00235	0.00518	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.00232	0.0051	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00225	0.00495	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.00212	0.00466	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00153	0.00336	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.00141	0.00311	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00127	0.00279	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00118	0.00259	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000998	0.0022	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000754	0.00166	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000724	0.00159	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000706	0.00155	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—amyotrophic lateral sclerosis	0.000326	0.000718	CbGpPWpGaD
